Medical Mutual - Health Plans for Life

Medical Drug Management

Medical Mutual recognized years ago that a comprehensive approach to managing specialty drugs, including high cost oncology drugs, covered under the medical and pharmacy benefits was critical to all of our customers. This was due to the fact that many new specialty drugs were being introduced to the marketplace and many of these specialty drugs are being administered to patients at their doctor’s office, a hospital outpatient facility, or stand-alone outpatient infusion center. These are not the types of drugs that could be obtained at a drug store.

As a result, Medical Mutual invested millions of dollars a couple of years ago to build and enhance upon the existing medical management approach that many health plans utilize and created a Medical Drug Management (MDM) program.

Components of our MDM program include:

  • Requiring a National Drug Code (NDC) on medications that require prior authorization
  • Editing outpatient and professional claims to ensure a medication has been approved and the dose administered matches the approval
  • Application of maximum daily dose edits on a number of targeted medications
  • Site of care management. Site of care management requires a number of targeted medications (e.g., immune globulins, Remicade, Soliris) to be administered in a non-hospital facility based location (i.e., home, provider’s office or ambulatory infusion site) unless certain medical necessity criteria are met.

As a result of the MDM program, we realized for our clients a medical specialty drug savings of more than $10 million during the first year of the program. Approximately 34 percent of the specialty drug spend under the medical benefit are oncology drugs. This savings is attributed to specialty drugs that were administered in a doctor’s office. Effective February 2015, we applied this program to specialty drugs administered at a hospital outpatient facility and stand-alone outpatient infusion center, which is where the remaining specialty drugs are being delivered on an outpatient basis.

Medical Mutual will continue to enhance our specialty drug management program to ensure we are managing our client’s health dollars to address market trends, new specialty drugs, and customer utilization.

Site of Care Management Program

Select specialty medications that are already subject to prior authorization requirements will be subject to site of care management beginning March 1, 2016. Previously, it was announced the program would take effect on January 15, 2016. Coverage for impacted medications is restricted to administration by home infusion, at a provider’s office or at an ambulatory infusion center.

Infusions administered in a hospital setting are not eligible for reimbursement unless the provider receives prior approval from Medical Mutual that the medical necessity criteria have been met.

New requests and renewals of a previously approved medication will be subject to site of care management. Please note the site of care criteria will not apply to members ages 18 and under. The standard prior authorization will apply, but the site of care questions will not.

View the list of medications subject to site of care management here.* View the list of medications requiring prior approval (including those subject to site of care management) or considered investigational here.

Medicare Part B Step Therapy Program

Medical Mutual requires review of some medical benefit drugs (primarily injectables and biologics) under step therapy requirements. These step therapy requirements will be in addition to already-existing, non-step therapy related policies and review requirements for Medicare Advantage members.

Please note that step therapy requirements do not apply to members who are already receiving active treatment with a non-preferred drug. Step therapy implementation will be administered in accordance with all guidance from the Centers for Medicare & Medicaid Services (CMS).

Furthermore, Medicare Advantage members subject to step therapy requirements have the right to ask for an exception or to appeal a request that was denied due to step therapy requirements.

View the list of medications subject to step therapy here. View the list of medications requiring prior approval (including those subject to site of care management) or considered investigational here.

Medical Drug Prior Approval Update

For more information on prescription medications requiring prior approval or that are considered investigational, and to view a complete list of our Corporate Medical Policies, visit Tools & Resources, Care Management, Corporate Medical Policies.

When these medications are provided under a member’s prescription drug benefit, please contact the pharmacy benefit manager at the number on the member’s identification card for prior approval requirements.


Additional Resources

This Medical Mutual website may contain links to other Internet sites (“Third Party Sites”) that are not maintained by or under the control of Medical Mutual. These links are provided solely for your convenience, and you access them at your own risk. Medical Mutual makes no warranties or representations about the contents of products, services or information offered in such Third Party Sites. Consequently, Medical Mutual is not and cannot be held responsible for the accuracy, copyright compliance, legality or decency of material contained in Third Party Sites linked to this Medical Mutual website.

© 2020 Medical Mutual®